ResearcherUniversity of PisaActive in the last 2 years
Chiara Corradi
Matched on ORCID iD 0000-0001-6216-9803; OpenAlex author ID A5008138515, A5030520028. Sources: OpenAlex.
Their work
- Papers
- 12 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 47
2021: 3 papers · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: 5 papers
Papers 12
- Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer. Co-author DOI 10.1016/j.semcancer.2024.12.005↗
- Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Co-author DOI 10.1016/j.semcancer.2025.01.003↗
- Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic predictors. Co-author DOI 10.1016/j.semcancer.2025.06.001↗
- Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. Co-author DOI 10.1093/mutage/gead034↗
- A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1093/mutage/geae012↗
- Potential association between PSCA rs2976395 functional variant and pancreatic cancer risk. Co-author DOI 10.1002/ijc.35046↗
- The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
- Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jmg-2022-108910↗
- Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression. First author DOI 10.3389/fonc.2023.1172606↗
- Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.33475↗
- Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival. First author DOI 10.1038/s41598-021-87130-0↗
- Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk. First author DOI 10.3389/fgene.2021.693933↗
Closest collaborators
The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniele Campa · 6 shared papers, 2021–2025 · strength 1.17
- Paper Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. DOI 10.1093/mutage/gead034↗
- Paper Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer. DOI 10.1016/j.semcancer.2024.12.005↗
- Paper Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic pr… DOI 10.1016/j.semcancer.2025.06.001↗
- Manuel Gentiluomo · 5 shared papers, 2021–2025 · strength 0.98
- Paper Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. DOI 10.1093/mutage/gead034↗
- Paper Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer. DOI 10.1016/j.semcancer.2024.12.005↗
- Paper Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic pr… DOI 10.1016/j.semcancer.2025.06.001↗
- Riccardo Farinella · 3 shared papers, 2023–2025 · strength 0.63
- Paper Long or short? Telomere length and pancreatic cancer and its precursor lesions, a narrative review. DOI 10.1093/mutage/gead034↗
- Paper Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. DOI 10.1016/j.semcancer.2025.01.003↗
- Paper Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression. DOI 10.3389/fonc.2023.1172606↗
- Gabriele Capurso · 3 shared papers, 2021–2025 · strength 0.49
- Paper Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer. DOI 10.1016/j.semcancer.2024.12.005↗
- Paper Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression. DOI 10.3389/fonc.2023.1172606↗
- Paper Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival. DOI 10.1038/s41598-021-87130-0↗
- Volkan N. Adsay · 2 shared papers, 2025 · strength 0.45
- Paper Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer. DOI 10.1016/j.semcancer.2024.12.005↗
- Paper Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic pr… DOI 10.1016/j.semcancer.2025.06.001↗
- Cosmeri Rizzato · 2 shared papers, 2023–2025 · strength 0.44
- Stefano Crippa · 2 shared papers, 2023–2025 · strength 0.40
- Luca Morelli · 2 shared papers, 2023–2025 · strength 0.36
- Paper Long-term recurrence of PDAC after resection for IPMN: A narrative review of the literature on clinical and biologic pr… DOI 10.1016/j.semcancer.2025.06.001↗
- Paper Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression. DOI 10.3389/fonc.2023.1172606↗
- Francesca Tavano · 2 shared papers, 2021–2025 · strength 0.33
- Giulia Peduzzi · 1 shared paper, 2025 · strength 0.28
- Paolo Riccardo Camisa · 1 shared paper, 2025 · strength 0.25
- Barbara Włodarczyk · 1 shared paper, 2025 · strength 0.25
- Juan Sáinz · 1 shared paper, 2025 · strength 0.25
- Federico Canzian · 2 shared papers, 2021–2023 · strength 0.24
- Paolo Giorgio Arcidiacono · 2 shared papers, 2021–2023 · strength 0.24
- Annalisa Comandatore · 1 shared paper, 2025 · strength 0.21
- Fabio Ausania · 1 shared paper, 2025 · strength 0.21
- Ingrid Garajová · 1 shared paper, 2025 · strength 0.21
- Gregorio Di Franco · 1 shared paper, 2025 · strength 0.21
- Elisa Giovannetti · 1 shared paper, 2025 · strength 0.21
- Verona Buociková · 1 shared paper, 2025 · strength 0.19
- Jörg Tost · 1 shared paper, 2025 · strength 0.19
- Seçil Ak Aksoy · 1 shared paper, 2025 · strength 0.19
- Božena Smolková · 1 shared paper, 2025 · strength 0.19
- Ján Strnádel · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.